US Patent 11129839 Minocycline compounds for biodefense
Patent 11129839 was granted and assigned to Paratek Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+462 characters)
Article
Patent abstract
Methods of treating or preventing a bacterial infection in a subject are disclosed herein, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon. Also disclosed is a pharmaceutical composition comprising the compound of the present invention for treating or preventing a bacterial infection in a subject, wherein the bacterial infection is caused by a bacterium which can be used as a biological weapon.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111298390
Date of Patent
September 28, 2021
0Patent Application Number
202002240
Date Filed
February 24, 2020
0Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111298390
Date of Patent
September 28, 2021
0Patent Application Number
202002240
Date Filed
February 24, 2020
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11129839 Minocycline compounds for biodefense
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11129839
Date of patent
September 28, 2021
Patent application number
20200224
Date Filed
February 24, 2020
Find more entities like US Patent 11129839 Minocycline compounds for biodefense
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.